These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28462453)

  • 1. Preclinical Screening for Treatments for Infantile Spasms in the Multiple Hit Rat Model of Infantile Spasms: An Update.
    Galanopoulou AS; Mowrey WB; Liu W; Li Q; Shandra O; Moshé SL
    Neurochem Res; 2017 Jul; 42(7):1949-1961. PubMed ID: 28462453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CPP-115, a vigabatrin analogue, decreases spasms in the multiple-hit rat model of infantile spasms.
    Briggs SW; Mowrey W; Hall CB; Galanopoulou AS
    Epilepsia; 2014 Jan; 55(1):94-102. PubMed ID: 24321005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms.
    Jequier Gygax M; Klein BD; White HS; Kim M; Galanopoulou AS
    Epilepsy Res; 2014 Jan; 108(1):98-108. PubMed ID: 24252685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carisbamate acutely suppresses spasms in a rat model of symptomatic infantile spasms.
    Ono T; Moshé SL; Galanopoulou AS
    Epilepsia; 2011 Sep; 52(9):1678-84. PubMed ID: 21770922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol does not affect spasms in the betamethasone-NMDA rat model of infantile spasms.
    Chachua T; Di Grazia P; Chern CR; Johnkutty M; Hellman B; Lau HA; Shakil F; Daniel M; Goletiani C; Velíšková J; Velíšek L
    Epilepsia; 2016 Aug; 57(8):1326-36. PubMed ID: 27328917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Hydroxybutyrate attenuates NMDA-induced spasms in rats with evidence of neuronal stabilization on MR spectroscopy.
    Yum MS; Lee M; Woo DC; Kim DW; Ko TS; Velíšek L
    Epilepsy Res; 2015 Nov; 117():125-32. PubMed ID: 26452206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential effect of ganaxolone in an animal model of infantile spasms.
    Yum MS; Lee M; Ko TS; Velíšek L
    Epilepsy Res; 2014 Nov; 108(9):1492-500. PubMed ID: 25219352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AQB-565 shows promise in preclinical testing in the model of epileptic spasms during infancy: Head-to-head comparison with ACTH.
    Chern CR; Chern CJ; Velíšková J; Velíšek L
    Epilepsy Res; 2019 May; 152():31-34. PubMed ID: 30875634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model of symptomatic infantile spasms syndrome.
    Scantlebury MH; Galanopoulou AS; Chudomelova L; Raffo E; Betancourth D; Moshé SL
    Neurobiol Dis; 2010 Mar; 37(3):604-12. PubMed ID: 19945533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptogenic effects of rapamycin in a model of infantile spasms due to structural lesions.
    Akman O; Briggs SW; Mowrey WB; Moshé SL; Galanopoulou AS
    Epilepsia; 2021 Aug; 62(8):1985-1999. PubMed ID: 34212374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation in epileptogenesis: Insights and translational perspectives from new models of epilepsy.
    Barker-Haliski ML; Löscher W; White HS; Galanopoulou AS
    Epilepsia; 2017 Jul; 58 Suppl 3(Suppl 3):39-47. PubMed ID: 28675559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and new candidate treatments for infantile spasms and early life epileptic encephalopathies: A view from preclinical studies.
    Galanopoulou AS; Moshé SL
    Neurobiol Dis; 2015 Jul; 79():135-49. PubMed ID: 25968935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling new therapies for infantile spasms.
    Chudomelova L; Scantlebury MH; Raffo E; Coppola A; Betancourth D; Galanopoulou AS
    Epilepsia; 2010 Jul; 51 Suppl 3(Suppl 3):27-33. PubMed ID: 20618396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infantile spasms: criteria for an animal model.
    Stafstrom CE; Holmes GL
    Int Rev Neurobiol; 2002; 49():391-411. PubMed ID: 12040904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pulse rapamycin therapy for infantile spasms and associated cognitive decline.
    Raffo E; Coppola A; Ono T; Briggs SW; Galanopoulou AS
    Neurobiol Dis; 2011 Aug; 43(2):322-9. PubMed ID: 21504792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam in the treatment of infantile spasms.
    Lawlor KM; Devlin AM
    Eur J Paediatr Neurol; 2005; 9(1):19-22. PubMed ID: 15701562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vigabatrin therapy implicates neocortical high frequency oscillations in an animal model of infantile spasms.
    Frost JD; Le JT; Lee CL; Ballester-Rosado C; Hrachovy RA; Swann JW
    Neurobiol Dis; 2015 Oct; 82():1-11. PubMed ID: 26026423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acthar® Gel (repository corticotropin injection) dose-response relationships in an animal model of epileptic spasms.
    Le JT; Frost JD; Swann JW
    Epilepsy Behav; 2021 Mar; 116():107786. PubMed ID: 33548914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACTON PROLONGATUM® suppresses spasms head to head with Acthar® Gel in the model of infantile spasms.
    Chern CR; Chern CJ; Velíšková J; Velíšek L
    Epilepsy Behav; 2020 Apr; 105():106950. PubMed ID: 32092460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile spasms and Down syndrome: a new animal model.
    Cortez MA; Shen L; Wu Y; Aleem IS; Trepanier CH; Sadeghnia HR; Ashraf A; Kanawaty A; Liu CC; Stewart L; Snead OC
    Pediatr Res; 2009 May; 65(5):499-503. PubMed ID: 19190545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.